MicrobiologybioRxivPreprint
Development of amidase-dependent pyrazinoic acid prodrugs with activity against pyrazinamide resistant Mycobacterium tuberculosis
C. Levine, R. Jadhav, P. Yan…·P. Kumar
This paper develops amidase-dependent pyrazinoic acid prodrugs that bypass PncA activation, showing efficacy against PZA-resistant Mtb.
DOI 10.1101/2022.07.05.496887